| Negligible-cost and weekend-free chemically defined human iPSC culture HH Kuo, X Gao, JM DeKeyser, KA Fetterman, EA Pinheiro, CJ Weddle, ... Stem Cell Reports 14 (2), 256-270, 2020 | 114 | 2020 |
| A type 2 ryanodine receptor variant associated with reduced Ca2+ release and short-coupled torsades de pointes ventricular arrhythmia Y Fujii, H Itoh, S Ohno, T Murayama, N Kurebayashi, H Aoki, M Blancard, ... Heart Rhythm 14 (1), 98-107, 2017 | 86 | 2017 |
| An African loss-of-function CACNA1C variant p.T1787M associated with a risk of ventricular fibrillation M Blancard, A Debbiche, K Kato, C Cardin, G Sabrina, E Gandjbakhch, ... Scientific reports 8 (1), 14619, 2018 | 12 | 2018 |
| A SPRY1 domain cardiac ryanodine receptor variant associated with short-coupled torsade de pointes Z Touat-Hamici, M Blancard, R Ma, L Lin, Y Iddir, I Denjoy, A Leenhardt, ... Scientific Reports 11 (1), 5243, 2021 | 11 | 2021 |
| Pharmacogenomic screening of drug candidates using patient-specific hiPSC-derived cardiomyocyte high-throughput calcium imaging M Blancard, KA Fetterman, PW Burridge Pharmacogenomics in Drug Discovery and Development, 241-253, 2022 | 4 | 2022 |
| A type 2 ryanodine receptor variant in the helical domain 2 associated with an impairment of the adrenergic response M Blancard, Z Touat-Hamici, Y Aguilar-Sanchez, L Yin, G Vaksmann, ... Journal of Personalized Medicine 11 (6), 579, 2021 | 3 | 2021 |
| A loss-of-function CACNA1C variant, p. T1787M, associated with risk of ventricular fibrillation in Africans M Blancard, A Debbiche, K Kato, C Cardin, S Guichard, E Gandjbakhch, ... Archives of Cardiovascular Diseases Supplements 10 (2), 194, 2018 | 1 | 2018 |
Paul W. BurridgeAssociate Professor, Northwestern UniversityVerified email at northwestern.edu
